Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MEM 1003 for the Treatment of Patients With Bipolar I Disorder Suffering Acute Manic or Mixed Episodes

NCT00374920 is registered in ClinicalTrials.gov with Memory Pharmaceuticals as lead sponsor.

NCT NCT00374920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00374920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MEM 1003 for the Treatment of Patients With Bipolar I Disorder Suffering Acute Manic or Mixed Episodes
Lead sponsor
Memory Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2006
Completion date
March 31, 2007
Enrollment
60
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder with manic or mixed episodes